MedPath

Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration

Completed
Conditions
Renal Insufficiency
Registration Number
NCT01467271
Lead Sponsor
Guerbet
Brief Summary

The main purpose of this study is to prospectively estimate the incidence of Nephrogenic Systemic Fibrosis (NSF) in patients with moderate to severe renal impairment after administration of Dotarem®

Detailed Description

All patients will be followed up during 2 years after Dotarem® administration to collect data on any suspected NSF or NSF-related symptoms

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
540
Inclusion Criteria
  • Patients with moderate to severe and end stage renal impairment or dialysis, scheduled for a contrast-enhanced Magnetic Resonance Imaging (MRI) with Dotarem
Exclusion Criteria
  • Patient who has received a Gadolinium Based Contrast Agent (GBCA) within the past 12 months prior to inclusion in this study except if the GBCA received is Dotarem

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of Patients With Moderate to Severe Renal Impairment Who Develop Nephrogenic Systemic Fibrosis (NSF) After Administration of DotaremAll patients were followed up during 2 years after Dotarem administration.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (27)

Hospital Italiano de Buenos Aires

🇦🇷

Buenos Aires, Argentina

University of Texas Health Science Center

🇺🇸

San Antonio, Texas, United States

H. Hartziekenhuis

🇧🇪

Roeselare, Belgium

Chung-Ang Univ. Medical Center

🇰🇷

Seoul, Korea, Republic of

Ewha Womans University Mokdong Hospital

🇰🇷

Seoul, Korea, Republic of

Hospital Clínico San Carlos de Madrid

🇪🇸

Madrid, Spain

Hospital Universitario de San Ignacio

🇨🇴

Bogota, Colombia

CRC Hospital Universitari Sant Joan de Reus

🇪🇸

Reus, Spain

Hôpital Bois-Guillaume - CHU de Rouen

🇫🇷

Rouen, France

Dişkapi Etlik Polikliniği

🇹🇷

Ankara, Turkey

Cardioangiologisches Centrum Bethanien

🇩🇪

Frankfurt, Germany

Uijeongbu St. Mary's Hospital

🇰🇷

Gyeonggi-do, Korea, Republic of

AZ St Lucas

🇧🇪

Gent, Belgium

Medeniyet University Goztepe Research and Training Hospital

🇹🇷

Istanbul, Turkey

University Hospital of North Staffodshire

🇬🇧

Stoke-on-Trent, United Kingdom

Covenant Health Care

🇺🇸

Saginaw, Michigan, United States

Hôpital Necker - Enfants malades

🇫🇷

Paris, France

Soonchunhyang Univ. Bucheon Hospital

🇰🇷

Gyeonggi-do, Korea, Republic of

UZ Brussel

🇧🇪

Brussel, Belgium

Universita campus Biomedico

🇮🇹

Roma, Italy

St. Louis University Medical Center

🇺🇸

Saint Louis, Missouri, United States

IATM (Instituto de alta tecnologia Medica de Antoquia)

🇨🇴

Medellin, Colombia

Instituto Tumori Pascale

🇮🇹

Napoli, Italy

Institute of Radiology and Neuroradiology

🇩🇪

Frankfurt, Germany

Ospedale Santa Maria

🇮🇹

Pozzuoli, Italy

Abington Memorial Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

Royal Liverpool University Hospital

🇬🇧

Liverpool, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath